(NASDAQ: RMTI) Rockwell Medical's forecast annual revenue growth rate of 9.22% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 7.91%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.28%.
Rockwell Medical's revenue in 2026 is $67,680,000.On average, 4 Wall Street analysts forecast RMTI's revenue for 2026 to be $2,917,605,032, with the lowest RMTI revenue forecast at $2,802,509,640, and the highest RMTI revenue forecast at $3,004,123,927.
In 2027, RMTI is forecast to generate $3,152,571,722 in revenue, with the lowest revenue forecast at $2,944,050,132 and the highest revenue forecast at $3,336,227,023.